SEC Form 4 · accession 0001179110-15-005204
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael L Kranda
Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 16, 2015 | S | 1,700 | $72.61 | D | 3,042 | D | |
| Common StockF3 | Mar 16, 2015 | S | 800 | $73.25 | D | 2,242 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan entered into on August 20, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.00 to $72.98 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.02 to $73.52 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.